TRx up 4% in the third quarter of 2017 as compared to the second quarter, and were flat year-over-year.
Pernix added that the deal brings the company a unique product franchise at early stages of launch, with an attractive competitive environment, and is an excellent strategic fit with the company's CNS focus, providing immediate sales synergies in a previously untapped market segment for Silenor
Doxepin (sold as Silenor
) has only a few side effects.
Recently, the drug doxepin (Silenor
) was approved for the treatment of insomnia.
M2 PHARMA-May 2, 2013-Paladin Labs Inc announces availibility of insomnia drug Silenor
in Canada(C)2013 M2 COMMUNICATIONS
The tricyclic antidepressant doxepin (Silenor
) was approved for insomnia in 2010 at 3-mg and 6-mg doses, but it cannot be used with monoamine oxidase inhibitors.
New medications, including doxepin (Silenor
) 3 to 6 mg, Lunesta in tapering doses 3-2-1 mg, Rozerem 8 mg, and Saphris (for anxiety stabilization and sleep effect), are quite useful in stabilizing individuals.
), a drug that was initially developed to treat depression, was approved by the FDA last year for treatment of insomnia characterized by waking frequently or waking too early and not being able to return to sleep.
The approval earlier this month of Somaxon's Silenor
(doxepin) for insomnia characterized by trouble staying asleep, means a second nonscheduled insomnia medication will enter the market.
Food and Drug Administration for its histamine-blocking drug Silenor
as a sleep aid.
"During the first quarter of 2009 we continued to focus on our key corporate objectives, notably to gain regulatory approval for Silenor
, to secure a commercial partnership for Silenor
and to improve our financial outlook," said Richard W.
M2 EQUITYBITES-May 2, 2013-Paladin Labs Inc announces availibility of insomnia drug Silenor
in Canada(C)2013 M2 COMMUNICATIONS http://www.m2.com